| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | 0.075 | 0.02 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.097 | 0.02 |
| mRNA | SB 216763 | GDSC1000 | pan-cancer | AAC | -0.082 | 0.03 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.12 | 0.03 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.064 | 0.03 |
| mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.073 | 0.03 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | -0.15 | 0.03 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | 0.075 | 0.03 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | -0.08 | 0.03 |